Stay updated on Talimogene Laherparepvec and Nivolumab Combination Clinical Trial

Sign up to get notified when there's something new on the Talimogene Laherparepvec and Nivolumab Combination Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Talimogene Laherparepvec and Nivolumab Combination Clinical Trial page

  1. Check
    6 days ago
    No Change Detected
  2. Check
    13 days ago
    No Change Detected
  3. Check
    20 days ago
    Change Detected
    Summary
    The study page now displays a 403 Forbidden error instead of the study details, indicating the record is currently inaccessible. Visitors viewing NCT02978625 will see an error page rather than the page content.
    Difference
    22%
    Check dated 2026-09-21T21:53:46.000Z thumbnail image
  4. Check
    27 days ago
    Change Detected
    Summary
    No additions or deletions are listed for this page, so there are no text changes to report.
    Difference
    0.1%
    Check dated 2026-09-14T17:46:07.000Z thumbnail image
  5. Check
    41 days ago
    Change Detected
    Summary
    The page now shows Revision: v3.6.6, replacing the previous Revision: v3.6.5. This indicates a minor update to the page's metadata without affecting the study information presented.
    Difference
    0.1%
    Check dated 2026-08-31T16:35:42.000Z thumbnail image
  6. Check
    55 days ago
    Change Detected
    Summary
    The study's update history now includes new dates: 2026-08-13, 2026-08-12, and 2026-08. Older dates 2026-07-31, 2026-07-30, and 2026-02 have been removed.
    Difference
    0.2%
    Check dated 2026-08-17T15:20:10.000Z thumbnail image
  7. Check
    62 days ago
    Change Detected
    Summary
    The page now shows Revision: v3.6.5, replacing the previous Revision: v3.6.4. This indicates a deployment of an updated page version.
    Difference
    0.0%
    Check dated 2026-08-10T12:32:42.000Z thumbnail image
  8. Check
    70 days ago
    Change Detected
    Summary
    UPMC Hillman Cancer Center was added as a participating location and University of Pittsburgh Cancer Institute (UPCI) was removed from the list of participating sites.
    Difference
    0.1%
    Check dated 2026-08-03T06:30:28.000Z thumbnail image

Stay in the know with updates to Talimogene Laherparepvec and Nivolumab Combination Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Talimogene Laherparepvec and Nivolumab Combination Clinical Trial page.